ERBB2 and breast cancer: We previously showed that pharmacological inhibition of NO, which would direct arginine metabolism towards PA synthesis, in normal mammary glands of mice induced the formation of precancerous lesions that highly expressed HER2, indicating a pathogenic relevance of NO inhibition to HER2+ breast cancer (12).